Nephritis
Therapeutic area
Nephrology
Rare disease
No
- Definition
- Inflammation of renal tissue.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Nephritis
- Therapeutic area
- Nephrology
- nephritis
- inflammation of kidney
- kidney inflammation
- Disease mechanisms
- Inflammatory
Sources for recorded values
- All therapeutic areas
- Nephrology
Sources for recorded values
- Severity
- Severe
- MONDO ID
- MONDO:0001166
- Parent condition
- MONDO:0005240
Related records
Broader conditions (7)
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Inflammatory disease
- Kidney disorder
- Urinary system disorder
Narrower conditions (52)
- Acute diffuse glomerulonephritis
- Acute poststreptococcal glomerulonephritis
- Acute proliferative glomerulonephritis
- Acute pyelonephritis
- Alport syndrome
- Alport syndrome 3b, autosomal recessive
- Anti-basement membrane glomerulonephritis
- Autoimmune glomerulonephritis
- Autosomal dominant Alport syndrome
- Autosomal recessive Alport syndrome
- Balkan nephropathy
- C3 glomerulonephritis
- Chronic pyelonephritis
- Chronic rapidly progressive glomerulonephritis
- Complement 3 glomerulopathy
- Complement factor H deficiency
- Crescentic glomerulonephritis
- Dense deposit disease
- Diffuse glomerulonephritis
- Digenic Alport syndrome
Trials (50)
- A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
- A Study of RG-012 in Subjects With Alport Syndrome
- A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
- A Study of Telitacicept in Lupus Nephritis
- A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
- A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
- A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy
- An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
- Atacicept in Multiple Glomerular Diseases
- CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
- CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
- Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy
- Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis
- Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
- DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
- Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
- FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects
Drugs in development (12)
- Alemtuzumab Phase 1
- Bindarit Phase 3
- Cyclophosphamide Phase 2
- Filgrastim Phase 2
- Fludarabine Phase 2
- Gemcitabine
- Lenograstim Phase 1
- Methylprednisolone Phase 2
- Ocrelizumab Phase 3
- Pegfilgrastim Phase 1
- Rituximab Phase 2
- Rolafagrel Phase 2
Other linked drugs (1)
- Acetoside